Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Smith+Nephew $1 billion notes offering
Davis Polk advised Smith & Nephew plc in connection with the establishment of a WKSI shelf and its debut SEC-registered…
Aziyo Biologics $50 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $50 million initial public…
NanoString Technologies $216.2 million follow-on offering
Davis Polk advised the joint book-running managers in connection with a $216.2 million public offering of 5,750,000…
Owens & Minor $200 million follow-on offering
Davis Polk advised the joint book-running managers and representatives to the underwriters in connection…
Beam Therapeutics $127 million offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering of 5,750,000 common…
Biondvax Pharmaceuticals $100 million at-the-market offering
Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its…
Coloplast acquisition of a minority interest in Francis Medical
Davis Polk advised Coloplast A/S in connection with its strategic equity investment in Francis Medical, Inc.Coloplast A/S is…
Gilead Sciences $7.25 billion senior notes offering
Davis Polk advised Gilead Sciences, Inc. in connection with an SEC-registered offering of $7.25 billion aggregate principal…
Hologic $950 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by…
Medtronic Global Holdings €6.25 billion notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €6.25…